BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 11172219)

  • 1. Recurrent atypical fibroxanthoma of the cheek.
    Skoulas IG; Price M; Andrew JE; Kountakis SE
    Am J Otolaryngol; 2001; 22(1):73-5. PubMed ID: 11172219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localized cutaneous metastases from an atypical fibroxanthoma.
    Giuffrida TJ; Kligora CJ; Goldstein GD
    Dermatol Surg; 2004 Dec; 30(12 Pt 2):1561-4. PubMed ID: 15606841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superficial malignant fibrous histiocytoma presenting as recurrent atypical fibroxanthoma.
    Ly H; Selva D; James CL; Huilgol SC
    Australas J Dermatol; 2004 May; 45(2):106-9. PubMed ID: 15068457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermatoscopic features of cutaneous atypical fibroxanthoma: three cases.
    Bugatti L; Filosa G
    Clin Exp Dermatol; 2009 Dec; 34(8):e898-900. PubMed ID: 20055861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An unusual presentation of atypical fibroxanthoma.
    Vandergriff TW; Reed JA; Orengo IF
    Dermatol Online J; 2008 Jan; 14(1):6. PubMed ID: 18319023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical fibroxanthoma of the external ear in a cardiac transplant recipient: case report and the causal role of the immunosuppressive therapy.
    Ferri E; Iaderosa GA; Armato E
    Auris Nasus Larynx; 2008 Jun; 35(2):260-3. PubMed ID: 17804184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma simulating atypical fibroxanthoma.
    Sangüeza M; Zelger B
    Am J Dermatopathol; 2007 Dec; 29(6):551-4. PubMed ID: 18032950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical fibrous histiocytoma and atypical fibroxanthoma: presentation of two cases.
    Kram A; Stańczyk J; Woyke S
    Pol J Pathol; 2003; 54(4):267-71. PubMed ID: 14998296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical fibroxanthoma/malignant fibrous histiocytoma.
    Marcet S
    Dermatol Ther; 2008; 21(6):424-7. PubMed ID: 19076618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More than 2 decades of treating atypical fibroxanthoma at mayo clinic: what have we learned from 91 patients?
    Ang GC; Roenigk RK; Otley CC; Kim Phillips P; Weaver AL
    Dermatol Surg; 2009 May; 35(5):765-72. PubMed ID: 19389106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent Atypical Fibroxanthoma Versus Malignant Fibrous Histiocytoma.
    Branch LG; Albertini JG; Leshin B
    J Craniofac Surg; 2015 Jun; 26(4):e322-3. PubMed ID: 26080249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical fibroxanthoma presenting in a patient with stage III mycosis fungoides.
    Avshalumov K; Williford P; Sangueza OP; Goldenberg G
    J Dermatolog Treat; 2008; 19(2):118-20. PubMed ID: 18484429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical staining of CD10 in atypical fibroxanthomas.
    Hultgren TL; DiMaio DJ
    J Cutan Pathol; 2007 May; 34(5):415-9. PubMed ID: 17448198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
    de Feraudy S; Mar N; McCalmont TH
    Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma.
    Gleason BC; Calder KB; Cibull TL; Thomas AB; Billings SD; Morgan MB; Hiatt KM; Smoller BR
    J Cutan Pathol; 2009 May; 36(5):543-7. PubMed ID: 19476522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous sarcomas and sarcomatoid neoplasms of the skin.
    Wick MR; Fitzgibbon J; Swanson PE
    Semin Diagn Pathol; 1993 May; 10(2):148-58. PubMed ID: 8396271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical fibroxanthoma: review of the literature and summary of 13 patients treated with mohs micrographic surgery.
    Seavolt M; McCall M
    Dermatol Surg; 2006 Mar; 32(3):435-41; discussion 439-41. PubMed ID: 16640694
    [No Abstract]   [Full Text] [Related]  

  • 18. CD117 immunoreactivity in atypical fibroxanthoma.
    Mathew RA; Schlauder SM; Calder KB; Morgan MB
    Am J Dermatopathol; 2008 Feb; 30(1):34-6. PubMed ID: 18212542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical fibroxanthoma: clinicopathologic determinants for recurrence and implications for surgical management.
    Davidson JS; Demsey D
    J Surg Oncol; 2012 May; 105(6):559-62. PubMed ID: 22025342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clear cell atypical fibroxanthoma:a clinicopathologic study.
    Crowson AN; Carlson-Sweet K; Macinnis C; Taylor JR; Battaglia T; LaMar WL; Minor D; Sutter S; Hill T
    J Cutan Pathol; 2002 Jul; 29(6):374-81. PubMed ID: 12135470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.